Subtopic Deep Dive

P2X7 Receptor in Inflammation
Research Guide

What is P2X7 Receptor in Inflammation?

The P2X7 receptor is an ATP-gated ion channel on immune cells that triggers inflammasome activation, IL-1β release, and inflammatory responses through pore formation and nonclassical secretion pathways.

P2X7 activation by extracellular ATP leads to potassium efflux, NLRP3 inflammasome assembly, and cytokine maturation in macrophages and microglia (Pelegrín and Surprenant, 2006; 1421 citations). Studies show Pannexin-1 forms large pores enabling IL-1β release, while exosome shedding provides an alternative secretion mechanism (Qu et al., 2007; 549 citations). Over 10 key papers since 2006 explore its roles in infection, tumors, and glial inflammation (Di Virgilio et al., 2017; 1152 citations).

Curated Papers

Key Challenges

Why It Matters

P2X7 receptor modulation targets chronic inflammation in arthritis, neuroinflammation, and cancer, where elevated extracellular ATP activates immune responses (Di Virgilio et al., 2017). In tumors, ATP levels reach hundreds of micromolar, promoting IL-1β-driven growth via P2X7 (Pellegatti et al., 2008; 653 citations). Antagonists block inflammasome-dependent cytokine storms, offering therapies for sepsis and autoimmune diseases (Di Virgilio and Adinolfi, 2016; 542 citations). DAMPs from cell death amplify P2X7 signaling, linking tissue damage to adaptive immunity (Vénéreau et al., 2015; 631 citations).

Key Research Challenges

Pore Formation Mechanisms

Debate persists on whether Pannexin-1 or P2X7 itself forms the large permeability pore for IL-1β release (Pelegrín and Surprenant, 2006; 1421 citations). Alternative paths like exosome release complicate models (Qu et al., 2007; 549 citations). Distinguishing channel vs. pore states requires advanced electrophysiology.

Tissue-Specific Regulation

P2X7 responses vary across macrophages, glia, and tumor cells due to sphingomyelinase and ATP gradients (Bianco et al., 2009; 573 citations). In vivo imaging reveals tumor ATP levels orders higher than normal tissue (Pellegatti et al., 2008; 653 citations). Modeling context-dependent gating remains unresolved.

Therapeutic Selectivity

Antagonists must block pathological inflammation without impairing infection defense (Di Virgilio et al., 2017; 1152 citations). Balancing channel inhibition and cytokine suppression challenges drug design (Coddou et al., 2011; 479 citations). Clinical translation lags due to off-target effects.

Essential Papers

Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor

Pablo Pelegrı́n, Annmarie Surprenant · 2006 · The EMBO Journal · 1.4K citations

The P2X7 Receptor in Infection and Inflammation

Francesco Di Virgilio, Diego Dal Ben, Alba Clara Sarti et al. · 2017 · Immunity · 1.2K citations

Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase

Patrizia Pellegatti, Lizzia Raffaghello, Giovanna Bianchi et al. · 2008 · PLoS ONE · 653 citations

Our results show that ATP in the tumour interstitium is in the hundreds micromolar range, while it is basically undetectable in healthy tissues. Here we show that a chimeric plasma membrane-targete...

DAMPs from Cell Death to New Life

Emilie Vénéreau, Chiara Ceriotti, Marco E. Bianchi · 2015 · Frontiers in Immunology · 631 citations

Our body handles tissue damage by activating the immune system in response to intracellular molecules released by injured tissues [damage-associated molecular patterns (DAMPs)], in a similar way as...

ATP synthesis and storage

Massimo Bonora, Simone Patergnani, Alessandro Rimessi et al. · 2012 · Purinergic Signalling · 594 citations

Acid sphingomyelinase activity triggers microparticle release from glial cells

Fabio Bianco, Cristiana Perrotta, Luisa Novellino et al. · 2009 · The EMBO Journal · 573 citations

Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages

Yan Qu, Luigi Franchi, Gabriel Núñez et al. · 2007 · The Journal of Immunology · 549 citations

Abstract Several mechanistically distinct models of nonclassical secretion, including exocytosis of secretory lysosomes, shedding of plasma membrane microvesicles, and direct efflux through plasma ...

Reading Guide

Foundational Papers

Start with Pelegrín and Surprenant (2006; 1421 citations) for Pannexin-1 pore mechanism, then Qu et al. (2007; 549 citations) for exosome alternatives, and Pellegatti et al. (2008; 653 citations) for in vivo ATP imaging establishing inflammatory context.

Recent Advances

Di Virgilio et al. (2017; 1152 citations) synthesizes infection/inflammation roles; Huang et al. (2021; 427 citations) covers human diseases; Di Virgilio and Adinolfi (2016; 542 citations) links to tumor growth.

Core Methods

Patch-clamp electrophysiology for gating (Coddou et al., 2011); plasma membrane luciferase for ATP detection (Pellegatti et al., 2008); inhibitors and siRNA for Pannexin/inflammasome validation (Pelegrín and Surprenant, 2006).

How PapersFlow Helps You Research P2X7 Receptor in Inflammation

Discover & Search

Research Agent uses citationGraph on Pelegrín and Surprenant (2006) to map 1421 citing papers linking P2X7 to inflammasomes, then findSimilarPapers uncovers Di Virgilio et al. (2017) for infection contexts, while exaSearch queries 'P2X7 tumor ATP inflammation' to retrieve Pellegatti et al. (2008).

Analyze & Verify

Analysis Agent applies readPaperContent to extract pore vs. exosome mechanisms from Qu et al. (2007), verifies IL-1β secretion claims via verifyResponse (CoVe) against Di Virgilio et al. (2017), and runs PythonAnalysis on ATP concentration data from Pellegatti et al. (2008) for statistical thresholds (mean 200-500 μM), graded A via GRADE for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in P2X7 glial regulation by flagging underexplored sphingomyelinase links (Bianco et al., 2009), while Writing Agent uses latexEditText for inflammasome pathway revisions, latexSyncCitations to integrate 10 core papers, and exportMermaid to diagram ATP → P2X7 → NLRP3 cascades.

Use Cases

"Extract and plot extracellular ATP levels from tumor vs. healthy tissues in P2X7 papers."

Research Agent → searchPapers('P2X7 ATP tumor') → Analysis Agent → readPaperContent(Pellegatti 2008) → runPythonAnalysis(pandas parse μM data, matplotlib barplot) → researcher gets CSV-exported stats confirming 100-500 μM tumor ATP.

"Draft LaTeX figure of P2X7 pore formation with Pannexin-1 and citations."

Synthesis Agent → gap detection(Pannexin debates) → Writing Agent → latexGenerateFigure(P2X7 channel diagram) → latexSyncCitations(Pelegrín 2006, Qu 2007) → latexCompile → researcher gets PDF with 2-column figure and 5 synced refs.

"Find GitHub repos analyzing P2X7 inflammasome simulations."

Research Agent → searchPapers('P2X7 inflammasome model') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets repo with Python scripts for NLRP3 activation kinetics from Di Virgilio-inspired models.

Automated Workflows

Deep Research workflow scans 50+ P2X7 papers via citationGraph from Pelegrín (2006), structures NLRP3/IL-1β report with GRADE scores. DeepScan applies 7-step CoVe to verify ATP-tumor claims (Pellegatti 2008), checkpointing exosome data (Qu 2007). Theorizer generates hypotheses on P2X7-DAMP synergies from Vénéreau (2015) + Di Virgilio (2017).

Try Doxa for P2X7 Receptor in Inflammation Research

Frequently Asked Questions

What defines P2X7 receptor activation in inflammation?

ATP binding opens the P2X7 channel, causing K+ efflux and NLRP3 inflammasome assembly for IL-1β processing (Pelegrín and Surprenant, 2006).

What are main methods studying P2X7 secretion?

Electrophysiology measures channel currents, luciferase imaging quantifies extracellular ATP, and inhibitors test Pannexin-1 dependence (Pellegatti et al., 2008; Qu et al., 2007).

What are key papers on P2X7 in inflammation?

Pelegrín and Surprenant (2006; 1421 citations) on Pannexin pores; Di Virgilio et al. (2017; 1152 citations) on infection/inflammation; Qu et al. (2007; 549 citations) on exosome secretion.

What open problems exist in P2X7 research?

Unresolved pore identity (P2X7 vs. Pannexin), tissue-specific ATP thresholds, and selective antagonists without infection impairment (Di Virgilio et al., 2017; Coddou et al., 2011).